The global Celiac Disease Treatment Market was valued at USD 682.40 million in 2024, projected to reach USD 1667.73 million by 2032, with a CAGR of 11.88%. The U.S. market, valued at USD 231.15 million in 2024, is forecast to reach USD 547.95 million by 2032, growing at 11.45% annually.
Market growth is driven by improved diagnostic capabilities, rising prevalence of celiac disease, demand for gluten-free foods, advancements in enzyme-based therapies, and accessibility of treatments. Early detection is crucial for preventing chronic complications.
The U.S. accounts for a significant portion of the market due to high incidence rates. An estimated 2 million Americans have celiac disease, representing 1% of the global population. The country’s healthcare infrastructure and pharmaceutical development contribute to market growth.
Globally, increasing awareness of gluten intolerance, clinical research, expansion of gluten-free products, and regulatory support for new therapies are shaping the treatment landscape. The market is set to expand with growing demand for celiac disease therapies.
In 2024, the vitamins & minerals segment held the largest market share due to nutritional deficiency needs. The gluten-degrading enzymes segment is expected to witness rapid growth due to innovations in symptom management.
Retail pharmacies held the largest market share in 2024, with online pharmacies expected to grow rapidly. Consumers are increasingly turning to digital healthcare post-pandemic, driving demand for online pharmacy services.
North America dominated the market in 2024, with a 39.24% share due to advanced healthcare infrastructure and high disease prevalence. Asia Pacific is the fastest-growing region, driven by increased awareness, healthcare infrastructure development, and demand for gluten-free products.
Recent developments include Novartis receiving FDA approval for Xolair to reduce allergic reactions from food ingestion and Immunic, Inc. reporting positive data on IMU-856 in a clinical trial. IMU-856 is a small molecule targeting SIRT6 for chronic inflammatory conditions. The Celiac Disease Treatment Market Report provides insights on global incidence, prevalence, diagnosis, treatment trends, gluten-free product adoption, healthcare spending patterns, and treatment availability metrics in 2024. It helps identify high-burden regions, gaps in diagnostic access, and disparities in treatment availability across key global regions. Purchase the full report for in-depth analysis and outlook. Visit the link for more details: https://www.snsinsider.com/checkout/7257
SNS Insider is a leading market research and consulting agency providing clients with current, accurate market data, consumer insights, and opinions to make informed decisions. With a focus on changing circumstances, the company utilizes various techniques such as surveys, video talks, and focus groups globally. Contact [email protected] for more information or customization requests. Stay informed and confident in your decision-making with SNS Insider.
Read more at GlobeNewswire: Celiac Disease Treatment Market Size to Reach USD 1667.73